Skip to main content
. 2019 Sep 20;20(19):4674. doi: 10.3390/ijms20194674
1-42 amyloid-β 1-42
AD Alzheimer’s disease
APOE Apolipoprotein
CSF cerebrospinal fluid
DAT-SPECT 123I[FP-CIT] single photon emission computed tomography
DLB dementia with Lewy bodies
EEG electroencephalography
ELISA enzyme-linked immunosorbent assays
MCI mild cognitive impairment
MMSE Mini-Mental State Examination
MRI magnetic resonance imaging
p-tau tau phosphorylated at threonine 181
RBD REM (rapid eye movement) sleep behavior disorder
SCD Subjective cognitive decline
SRM selected reaction monitoring
t-tau total tau
VGF neurosecretory protein VGF